To study the effect of Unani formulation of paste in acne vulgaris.
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2024/02/062474
- Lead Sponsor
- Central Council for Research in Unani Medicine New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients of age group 15-60 years.
2. Clinically diagnosed patients of Buthur Labaniyya.
3. Patients Irrespective of the gender.
4. Patients with mild to moderate form of acne.
5. Patients who will agree to sign the informed consent form & follow the protocol.
1. Patients with severe form of acne.
2. Diagnosed patients of PCOD.
3. Patients having local wound and infection on face.
4. Pregnant and lactating women.
5. Patients with systemic diseases like DM, CKD, Chronic liver diseases,and history of Thyroid diseases or malignancies.
6. Patients on corticosteroid therapy, anti-convulsant therapy or taking OCP.
7. Patients suffering from other concomitant diseases like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Change in inflammatory lesions (Papules and Pustules) and non-inflammatory lesions (Open and Closed Comedones) (GAGS-Global Acne Grading System). <br/ ><br>2) Change in the inflammatory (Papules and Pustules) lesions based on photographs of lesions. <br/ ><br>3) Change in the quality of life of subjects based on the Dermatology Life Quality Index (DLQI).Timepoint: 0th day, 7th day, 14th day, 21st day, 28th day, 35th day, 42nd day
- Secondary Outcome Measures
Name Time Method 1) Effect on redness based on Clinical Erythema Assessment (CEA). <br/ ><br>2) Effect on eruptions based on Simple Grading System by Indian Authors.Timepoint: 0th day, 7th day, 14th day, 21st day, 28th day, 35th day, 42nd day.